Suppr超能文献

程序性细胞死亡蛋白1(PD-1)及其配体PD-L1是同种异体移植耐受所必需的。

Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.

作者信息

Wang Liqing, Han Rongxiang, Hancock Wayne W

机构信息

Department of Pathology and Laboratory Medicine, Joseph Stokes Jr Research Institute and Biesecker Pediatric Liver Center, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA 19104-4318, USA.

出版信息

Eur J Immunol. 2007 Oct;37(10):2983-90. doi: 10.1002/eji.200737583.

Abstract

Programmed cell death-1 (PD-1, CD279) and its widely expressed, inducible ligand, PD-L1 (CD274), together dampen T cell activation, but whether they are essential for allograft tolerance is unknown. We show, using gene-deficient mice and blocking mAbs in wild-type mice, that costimulation blockade is ineffectual in PD-1(-/-) or PD-L1(-/-) allograft recipients, or in wild-type allograft recipients treated with anti-PD-1 or anti-PD-L1 mAb. Alloreactive PD-1(-/-) CD4 and CD8 T cells had enhanced proliferation and cytokine production compared to wild-type controls, and anergy could not be induced in PD-1-deficient CD4 T cells. We conclude that without inhibitory signals from PD-1 ligation, alloantigen-induced T cell proliferation and expansion cannot be regulated by costimulation blockade, and peripheral tolerance induction cannot occur.

摘要

程序性细胞死亡蛋白1(PD-1,CD279)及其广泛表达的诱导性配体PD-L1(CD274)共同抑制T细胞活化,但它们对于同种异体移植耐受是否必不可少尚不清楚。我们使用基因缺陷小鼠并在野生型小鼠中使用阻断性单克隆抗体表明,共刺激阻断在PD-1基因敲除或PD-L1基因敲除的同种异体移植受体中无效 , 在用抗PD-1或抗PD-L1单克隆抗体治疗的野生型同种异体移植受体中也无效。与野生型对照相比,同种异体反应性PD-1基因敲除的CD4和CD8 T细胞具有增强的增殖和细胞因子产生,并且在缺乏PD- 的CD4 T细胞中不能诱导无反应性。我们得出结论,没有来自PD-1连接的抑制信号,同种异体抗原诱导的T细胞增殖和扩增就不能通过共刺激阻断来调节,并且不能发生外周耐受诱导。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验